Actively Recruiting
Dutch-AMR: Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Mitral Regurgitation
Led by UMC Utrecht · Updated on 2019-06-06
500
Participants Needed
6
Research Sites
782 weeks
Total Duration
On this page
Sponsors
U
UMC Utrecht
Lead Sponsor
N
Netherlands Heart Institute
Collaborating Sponsor
AI-Summary
What this Trial Is About
Rationale: Severe asymptomatic organic Mitral Valve (MV) regurgitation with preserved left ventricular (LV) function is a challenging clinical entity as data on the recommended treatment strategy for these patients are scarce and conflicting, which is reflected in current guidelines. European guidelines advocate a more conservative strategy i.e. watchful waiting, with yearly echocardiography, whilst American guidelines are more in favour of early surgery to reconstruct the MV, i.e. MV repair (in contrast to MV replacement) in order to prevent future LV dysfunction and complaints. A number of non-randomised trials show a favourable outcome of early surgery: in the study of Enriquez-Sarano et al. for instance, the early surgery strategy has shown to be associated with improved long-term survival, decreased cardiac mortality, and decreased morbidity compared with the conservative management \[1\]. On the other hand, non-randomised trials describe also that a conservative strategy (i.e. watchful waiting) can be safely accomplished. If facilitated surgery is performed in this population (50% at 10 years follow-up according to Rosenhek et al \[2\]), it has proven to be eventually associated with good perioperative and postoperative outcome when careful follow-up is being carried out \[2\]. Objective: To compare early MV repair versus watchful waiting in asymptomatic patients with severe organic mitral valve regurgitation and preserved left ventricular function. Study design: Multicenter, registry trial. Study population: 250 Asymptomatic patients (18-75 years old) with severe organic MV regurgitation and preserved left ventricular function. The current European Society of Cardiology (ESC) guidelines on Valvular Heart Disease will be applied \[3\]. These guidelines are also used in the Netherlands. Accordingly, patients with an indication for MV surgery will not be included. Intervention: Intervention will be early MV repair compared to a watchful waiting strategy.
CONDITIONS
Official Title
Dutch-AMR: Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Mitral Regurgitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years
- No symptoms or exercise limitations related to mitral valve disease
- Severe organic mitral valve regurgitation diagnosed by echocardiography
- Preserved left ventricular function with ejection fraction over 60% and end-systolic dimension under 45 mm
- Predicted likelihood of successful mitral valve repair over 90% by local heart team
You will not qualify if you...
- Pulmonary hypertension with pressure over 50 mmHg at rest
- Presence of atrial fibrillation on ECG or Holter monitoring
- Physical inability to undergo surgery as determined by heart team
- Other life-threatening medical conditions
- High expected surgical risk as assessed by heart team
- Moderate to severe kidney disease with eGFR less than 30 mL/min
- Flail mitral leaflet combined with left ventricular end-systolic diameter 40 mm or greater
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Amsterdam Medical Center (AMC)
Amsterdam, Netherlands
Actively Recruiting
2
Amphia Breda
Breda, Netherlands
Actively Recruiting
3
Medisch Spectrum Twente (MST)
Enschede, Netherlands
Actively Recruiting
4
Leiden University Medical Center (LUMC)
Leiden, Netherlands
Active, Not Recruiting
5
Maastricht UMC
Maastricht, Netherlands
Actively Recruiting
6
University Medical Center Utrecht (UMC Utrecht)
Utrecht, Netherlands, 3584 CX
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here